Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora(R) Significantly Relieves Short-Term Anxiety in Healthy Women
5/8/2008 9:54:17 AM
SALINAS, Calif.--(BUSINESS WIRE)--Next Pharmaceuticals announced today the results of a six-week, double-blind, placebo-controlled clinical study on Relora conducted on healthy women between the ages of 20 and 50. Relora significantly reduced short-term anxiety compared to the placebo group. The study conducted by Miami Research Associates, a clinical research organization in Miami, Florida, was published in Nutrition Journal, an open access peer-reviewed, online journal. Nutrition Journal can be referenced through BioMed Central and PubMed.
comments powered by